Investment Research report

Henry Schein, Inc.

NASDAQ:
HSIC
Previous Item
All Reports
Henry Schein, Inc.
A Fully Vetted Upside Case
Download Report
Henry Schein, Inc.
Download Report 2
Henry Schein, Inc.
Download Report 3
Henry Schein, Inc.
Download Report 4
Henry Schein, Inc.
Download Report 5
Henry Schein, Inc.
Download Report 6
Henry Schein, Inc.
Download Report 7

Research Overview

INDEX:
S&P 500
Sector:
Healthcare
Position:
Long
Date:
Sep 26, 2018

After conducting a forensic financial and accounting review, Spruce Point believes the upcoming spinoff of Henry Schein, Inc (NASDAQ: HSIC), an animal health business, will unlock substantial value for shareholders and be one of the fastest growing EBITDA story in the animal health sector. Based on our latest investigation, we estimate 30% to 50% upside potential.

The report includes:

  • A case for the fact that the growth of Vets First Choice is underappreciated by street
  • Evidence that Vets First Corp. could be the biggest growth story in animal health
Downloads & More

Research Assets & Releases

Join The Mailing List

Spruce Point Alerts & Updates

See the other side of the Wall Street hype machine.